TAK-659
C34015
Phase 1 small_molecule terminated
Quick answer
TAK-659 for Lymphoma, Non-Hodgkin is a Phase 1 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Lymphoma, Non-Hodgkin
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated